Actively Recruiting
Continuous Glucose Monitoring to Study Blood Sugar Control in Polycystic Ovarian Syndrome
Led by The Cleveland Clinic · Updated on 2026-10-06
40
Participants Needed
1
Research Sites
32 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating blood sugar control in individuals with polycystic ovarian syndrome PCOS. This observational study focuses on monitoring glucose levels to better understand how blood sugar is managed in this condition. Participants are adults aged 18 to 45 years with PCOS and a body mass index BMI over 25 kgm2. Participants will use an unblinded continuous glucose monitoring device called the Stelo glucose biosensor by Dexcom, which is worn on the arm and measures sugar levels under the skin. The device will be worn at specific times during the study. The study includes two blood draws, one at screening and one at six months, body composition measurements, and questionnaires at three and six months. Throughout the approximately six-month study period, participants will be asked to wear the glucose monitor and attend study visits for assessments. Researchers will evaluate glucose measurements, lifestyle behaviors, and the relationship between blood sugar control and PCOS. The study includes safety monitoring such as lab tests and questionnaires, and participants will be supported throughout their involvement.
CONDITIONS
Brief Title
Continuous Glucose Monitoring in Polycystic Ovarian Syndrome
Research Team
A
Andrea Parianos, MS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here